GB Sciences, Inc. (GBLX)

Market Cap	153.72K -90.6%
Revenue (ttm)	97.24K
Net Income	-1.06M
EPS	-0.00
Shares Out	512.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,279
Average Volume	22,867
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0004
52-Week Range	0.0000 - 0.5002
Beta	11.70
RSI	37.62
Earnings Date	Feb 6, 2026

About GB Sciences

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Scie...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: GBLX